AN ALZHEIMER’S drug hailed as a ‘miracle’ medicine for dementia may cause life-threatening brain bleeds in a third of ...

Obesity is a major global health issue, increasing the risk of heart disease, diabetes, and high blood pressure. Despite many ...

Treatment with donanemab (Kisunla) raised the risk of amyloid-related imaging abnormalities (ARIA) in people with early ...

Nonsteroidal anti-inflammatory drug use for over 2 years was associated with a lower risk for dementia, especially ...

There are now two fully approved drugs on the market that can, sometimes, slow down the progression of Alzheimer's disease. Both have been shown... Two patients navigate the new Alzheimer's drugs ...

A new Northwestern Medicine study publishing in Nature Medicine suggests a promising alternative to previous attempts to ...

St. Charles, Missouri, resident Sue Bell became one of the first Alzheimer's patients in the U.S. to receive the drug now ...

Research suggests potential health benefits beyond what popular diabetes and weight-loss drugs were first approved to treat.

There's rosemary, that's for remembrance,' says Ophelia in Shakespeare's Hamlet. So it is fitting that researchers would study a compound found in rosemary and sage -- carnosic acid -- for its impact ...

A new study suggests that women who use a popular hormonal menopause treatment later in life may be at a higher risk of developing Alzheimer’s disease.

Heidi McWilliams, a 10-year Palm Beach resident, is chair of the organization's inaugural event at the Palm Beach County ...

"But I'm not sure." That sort of uncertainty is common when it comes to Leqembi and Kisunla, two new Alzheimer's drugs approved since 2023. Both drugs clear the brain of a substance called beta ...